Search PubMed⌕ Search

SEARCH · Search PubMed

Results for “THIOURACIL”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 721 records · Page 40Linked to original sources
PubMed1999

Determination of thyreostatics in animal feed by micellar electrokinetic chromatography.

The determination of the thyreostatics 2-thiouracil, its derivatives (4-methyl-2-thiouracil, 4-propyl-2-thiouracil and 4-phenyl-2-thiouracil) and methimazole in manufactured dried animal feed by micellar electrokinetic chromatography (MEKC) is described. A 99 +/- 5% extraction yield at the 20 micrograms g-1 level (n = 8) was achieved by shaking the milled fodder with methanol-1 M NaOH (80 + 20). Aliquots of the supernatant were injected in a 75 microns x 33.5 cm uncoated silica capillary using pressure; separation was performed at 23 degrees C with 15 kV (positive polarity) in a background electrolyte (BGE) containing 40 mM sodium dihydrogenphosphate, 50 mM sodium dodecyl sulfate and 15 mM Tween 20 at pH 9. When the surfactants were added to the BGE, all the thyreostatics were well resolved and the fodder extracts showed lower backgrounds. The peaks appeared within the 2.25-5.2 min range with efficiencies in the 2.5 x 10(4)-8 x 10(4) range; methimazole appeared in the vicinity of the electroosmotic migration time. Calibration curves were linear within the studied range (20-200 micrograms ml-1, r2 > 0.998). Limits of detection in the extracts of spiked fodder samples ranged from 0.25 to 0.4 microgram ml-1, which corresponded to 0.6-1.0 microgram of drug per gram of fodder. Peak area repeatabilities were about 4% at the 20 micrograms ml-1 level.

Animal Feed↗
PubMed1989

In vitro thymidine uptake and incorporation into thymic and bursal lymphocytes from young hypothyroidic chickens.

Experiments were conducted to evaluate the ability of thymic and bursal lymphocytes from hypothyroidic chicks to take up 3H-thymidine. To produce hypothyroidism, chicks were fed a diet containing thiouracil (0.1%) from day of hatch to 3 weeks of age. At 1, 2 and 3 weeks of age, body weights were significantly lower for hypothyroid chicks, and at 2 and 3 weeks of age, the relative weights of the thymus and bursa were significantly less than those of controls. Furthermore, chicks treated with thiouracil had significantly lower serum concentrations of 3,5,3'-triiodothyronine (T3) and thyroxine (T4). Thymic cells from hypothyroid chicks incorporated less 3H-thymidine at 1 and 3 weeks of age as assessed by liquid scintillation counting and autoradiography. Liquid scintillation counts for labeled bursal cells from hypothyroid chicks were not lower at 1 week of age, but the counts were lower at 3 weeks of age. Autoradiographic studies with bursal cells revealed that 3H-thymidine incorporation was less, but not significantly less, in medium-size lymphocytes from thiouracil-treated chicks at both 1 and 3 weeks of age. Thymidine incorporation into large bursal cells was affected more by thiouracil treatment at 1 than 3 weeks of age.

Animals↗
PubMed1977

The role of thyroid hormone in the development of the chick corneal endothelium and epithelium.

Previous studies have established that thyroxine or thiouracil treatments affect the development of corneal transparency in the chick. The effects of these drugs on chick corneal epithelial and endothelial development were investigated because in the adult the integrity of these cell layers is necessary for the maintenance of corneal transparency. Chick embryos were treated with thiouracil or thyroxine at stage 36 or 38; the corneas were excised 2 to 12 days after treatment (between stages 38 and 45), and prepared for electron microscopy. The colloidal tracer ruthenium red was added during fixation to study epithelial and endothelial permeability and to stain the intercellular endothelial spaces. At all stages studied, the epithelium was impermeable to ruthenium red and this property was not affected by drug treatment. The epithelial barrier to this tracer is located in the outermost cell layer. The ease of penetration of ruthenium red through the endothelial intercellular spaces indicated the lack of zonular tight functions and the presence of gap functions in this cell layer. Thiouracil treatment delayed the development of the corneal epithelium so that at stage 45 it resembled epithelium from a normal embryo 3 stages younger. In normal animals, chick corneal endothelial development is characterized by an increasing degree of interdigitation of the lateral plasma membranes of adjacent endothelial cells with advancing embryonic age. Thiouracil treatment delayed this progressive development of adjacent cell membrane interdigitation. In contrast, thyroxine treatment accelerated the development of the lateral borders of the endothelial cells. It also appears that thyroid hormone can affect the development of the cell membranes of apposed cells in epithelium as well as the endothelium of the embryonic chick cornea.

Animals↗
PubMed1998

Determination of thyreostat residues from bovine matrices using high-performance liquid chromatography.

High-performance liquid chromatography (HPLC) methodologies were evaluated for the detection and quantification of thyreostatic drug residues in cattle serum and thyroid tissue. The paper details a protocol, using a simple ethyl acetate extraction for the determination of thiouracil, tapazole, methyl thiouracil, propyl thiouracil and phenyl thiouracil in thyroid tissue. Using two sequential HPLC injections, and quantitative analysis, in two steps, all five thyreostats were detectable at concentrations greater than 2.45-4.52 ng/g. Modifications to a published method for detection of thyreostatic residues in serum involving the addition of mercaptoethanol and a freezing step are described. The modifications improved sensitivity and allowed detection of the five thyreostats at levels greater than 16.98-35.25 ng/ml. Young bulls were treated with thyreostats to demonstrate the validity of the methodologies described. Administered thyreostats were not absorbed equally by the test animals and the compounds were not all detected in the serum samples removed at 7 days following drug withdrawal. These experiments indicate the necessity to be able to detect thyreostat residues in a variety of matrices.

Animals↗
PubMed1975

Hydrogen bonding abilities of 2,4-dithiouridine derivatives.

The base pairing ability of a di-2,4-thiouridine derivative was studied in carbon tetrachloride solutions by the methods of infrared spectroscopy. The strength of the association by hydrogen bonding was found to decrease in the following order: adenine-uracil, adenine-di-2,4-thiouracil, uracil-uracil, and di-2,4-thiouracil-di-2,4-thiouracil. These findings contrast with the previously demonstrated fact that poly(s2s4U) is strongly self-associated and does not form a complex with poly(A). To correlate these results, it is proposed that long range stabilizing forces are acting between the di-2,4-thiouracil residues in polynucleotide chains. This assumption also explains the existence of an ordered structure in the alternating copolymer poly(s2s4U-A).

Adenine Nucleotides↗
PubMed2003

First example of mu(3)-sulfido bridged mixed-valent triruthenium complex triangle Ru(III)(2)Ru(II)(O,O-acetylacetonate)(3)(mu-O,O,gamma-C-acetylacetonate)(3)(mu(3)-S) (1) incorporating simultaneous O,O- and gamma-C-bonded bridging acetylacetonate units. Synthesis, crystal structure, and spectral and redox properties.

The reaction of mononuclear ruthenium precursor [Ru(II)(acac)(2)(CH(3)CN)(2)] (acac = acetylacetonate) with the thiouracil ligand (2-thiouracil, H(2)L(1) or 6-methyl -2-thiouracil, H(2)L(2)) in the presence of NEt(3) as base in ethanol solvent afforded a trinuclear triangular complex Ru(3)(O,O-acetylacetonate)(3)(mu-O,O,gamma-C-acetylacetonate)(3)(mu(3)-sulfido) (1). In 1, each ruthenium center is linked to one usual O,O-bonded terminal acetylacetonate molecule whereas the other three acetylacetonate units act as bridging functions: each bridges two adjacent ruthenium ions through the terminal O,O-donor centers at one end and via the gamma-carbon center at the other end. Moreover, there is a mu(3)-sulfido bridging in the center of the complex unit, which essentially resulted via the selective cleavage of the carbon-sulfur bond of the thiouracil ligand. In diamagnetic complex 1, the ruthenium ions are in mixed valent Ru(III)Ru(III)Ru(II) state, where the paramagnetic ruthenium(III) ions are antiferromagnetically coupled. The single crystal X-ray structure of 1 showed two crystallographically independent C(3)-symmetric molecules, Ru(3)(O,O-acetylacetonate)(3)(mu-O,O,gamma-C-acetylacetonate)(3)(mu(3)-S) (1), in the asymmetric unit. Bond distances of both crystallographically independent molecules are almost identical, but there are some significant differences in bond angles (up to 6 degrees ) and interplanar angles (up to 8 degrees ). Each ruthenium atom exhibits a distorted octahedral environment formed by four oxygen atoms, two from each of the terminal and bridging acetylacetonate units, one gamma-carbon of an adjacent acetylacetonate ligand, and the sulfur atom in the center of the complex. In agreement with the expected 3-fold symmetry of the complex molecule, the (1)H and (13)C NMR spectra of 1 in CDCl(3) displayed signals corresponding to two types of ligand units. In dichloromethane solvent, 1 exhibited three metal center based successive quasireversible redox processes, Ru(III)Ru(III)Ru(III)-Ru(III)Ru(III)Ru(II) (couple I, 0.43 V vs SCE); Ru(III)Ru(III)Ru(IV)-Ru(III)Ru(III)Ru(III) (couple II, 1.12 V); and Ru(III)Ru(III)Ru(II)-Ru(III)Ru(II)Ru(II) (couple III, -1.21 V). However, in acetonitrile solvent, in addition to the three described couples [(couple I), 0.34 V; (couple II), 1.0 V; (couple III), -1.0], one irreversible oxidative response (Ru(III)Ru(III)Ru(IV) --> Ru(III)Ru(IV)Ru(IV) or oxidation of the coordinated sulfide center) appeared at E(pa), 1.50 V. The large differences in potentials between the successive couples are indicative of strong coupling between the ruthenium ions in the mixed-valent states. Compound 1 exhibited a moderately strong charge-transfer (CT) transition at 654 nm and multiple ligand based intense transitions in the UV region. In the Ru(III)Ru(III)Ru(III) (1(+)) state, the CT band was slightly blue shifted to 644 nm; however, the CT band was further blue shifted to 520 nm on two-electron oxidation to the Ru(III)Ru(III)Ru(IV) (1(2+)) state with a reduction in intensity.

Journal Article↗
PubMed1992

Structure-activity relationships of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine analogues: effect of substitutions at the C-6 phenyl ring and at the C-5 position on anti-HIV-1 activity.

The effect of substitution on the pyrimidine moiety of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT) and 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)-2-thiothymine (HEPT-S) on anti-HIV-1 activity was investigated by synthesizing a series of 5-methyl-6-(arylthio) and 5-substituted-6-(phenylthio) derivatives. Preparation of the 5-methyl-6-(arylthio) derivatives was carried out based on either LDA lithiation of 1-[[2-(tert-butyldimethylsiloxy)ethoxy]methyl]thymine (3) and 1-[[2-(tert-butyldimethylsiloxy)ethoxy]methyl]-2-thiothymine (4) followed by reaction with diaryl disulfides or an addition-elimination reaction of 1-[[2-(tert-butyldimethylsiloxy)ethoxy]-methyl]-6- (phenylsulfinyl)thymine (31) with aromatic thiols. Preparation of the 5-substituted-6-(phenylthio) derivatives was carried out based on either C-5 lithiation of the 1-[[2-(tert-butyldimethylsiloxy)ethoxy]methyl]-6-(phenylthio)uraci l (41) with LTMP or the LDA lithiation of 5-alkyl-1-[[2-(tert-butyldimethylsiloxy)ethoxy]methyl]-2-thiouraci l derivatives 45-47. Substitution at the meta position of the C-6-(phenylthio) ring by the methyl group improved the original anti-HIV-1 activity of HEPT, and introduction of two m-methyl groups to the phenylthio ring further potentiated the activity [EC50: 6-[(3,5-dimethylphenyl)thio]-1-[(2-hydroxyethoxy)methyl]thymine (28), 0.26 microM; 6-[(3,5-dimethylphenyl)thio]-1-[(2-hydroxyethoxy)methyl]-2-thiothymin e (30), 0.22 microM]. When the 5-methyl group was replaced by an ethyl or an isopropyl group, the anti-HIV-1 activity of HEPT was also improved remarkably [EC50: 5-ethyl-1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)-2-thiouracil (48), 0.11 microM; 5-isopropyl-1-[(2-hydroxyethoxy)-methyl]-6-(phenylthio)-2-thiouracil (50), 0.059 microM; 5-ethyl-1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)-2-thiouracil (54), 0.12 microM; 5-isopropyl-1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)-2-thiouracil (56), 0.063 microM]. 6-[(3,5-Dimethylphenyl)thio]-5-ethyl-1-[(2-hydroxyethoxy)methyl]thymine derivatives 51 and 57 and 6-[(3,5-dimethylphenyl)thio]-5-isopropyl-1-[(2- hydroxyethoxy)methyl]thymine derivatives 52 and 58 inhibited the replication of HIV-1 in the nanomolar concentration range.

Antiviral Agents↗
PubMed1978

Sequential deiodination of thyroxine in rat liver homogenate.

Rat liver homogenate was incubated at 37 degrees C with thyroxine, 3,3',5-tri-iodothyronine, 3,3',5'-tri-iodothyronine or 3,3'-di-iodothyronine. The degradation or accumulation of these compounds was measured by specific radioimmunoassays. (1) Production of 3,3',5-tri-iodothyronine from thyroxine was highest at pH 6.0--6.5 and was markedly stimulated by the addition of dithiothreitol and effectively inhibited in the presence of 6-propyl-2-thiouracil. (2) Accumulation of 3,3',5'-tri-iodothyronine on incubation of thyroxine with homogenate was only observed above pH 8.5. Otherwise the product was converted into 3,3'-di-iodothyronine too rapidly to allow its measurement. By measuring 3,3'-di-iodothyronine it was deduced that 5-deiodination of thyroxine was most effective at approx. pH 8.0. Dithiothreitol powerfully stimulated this reaction and 6-propyl-2-thiouracil strongly inhibited. (3) Monodeiodination of the tyrosine ring of 3,3',5-tri-iodothyronine was the slowest reaction, was optimal at pH 8.0 and was less affected by dithiothreitol and 6-propyl-2-thiouracil than the above reactions. (4) 5'-Deiodination of 3,3',5'-tri-iodothyronine was extremely rapid, with a pH optimum probably at about 6.5. Owing to the high reaction rate under the conditions used it was not possible to assess the effects of dithiothreitol and 6-propyl-2-thiouracil.

Animals↗
PubMed1986

A new class of propylthiouracil analogs: comparison of 5'-deiodinase inhibition and antithyroid activity.

After in vivo administration, propylthiouracil (PTU) inhibits not only thyroid iodide uptake and organification, but also T4 5'-deiodinase activity in most peripheral organs. The present report describes the effects of some previously untested 6-substituted 2-thiouracil derivatives on in vivo and in vitro iodide uptake and organification, and on T4 5'-deiodinase activity in liver and pituitary homogenates. When added to homogenates, many analogs were as potent or more potent than PTU in inhibiting hepatic T4 5'-deiodinase activity. Three derivatives, 6-anilino-2-thiouracil (A compound), 6-(p-ethylanilino)2-thiouracil (B compound), and 6-(p-n-butylanilino) 2-thiouracil (C compound), which were among the most potent inhibitors of hepatic T4 5'-deiodinase, when added in vitro inhibited T4 5'-deiodinase activity in liver homogenates after in vivo administration. When added to pituitary homogenates prepared from hypothyroid rats, these compounds also significantly inhibited pituitary T4 5'-deiodinase activity. In a concentration of 1 mM in the presence of 20 mM dithiothreitol, the percent inhibition of pituitary T4 5'-deiodinase activity was 19.7 +/- 7.4 (mean +/- SE), 34.0 +/- 3.2, 47.3 +/- 3.1, and 89.0 +/- 1.0 for PTU and the A, B, and C compounds, respectively (P less than 0.05 for all groups vs. one another and vehicle). Despite their ability to inhibit hepatic T4 5'-deiodinase activity, none of the 13 analogs tested altered thyroid iodide uptake or organification after administration of 0.1 mg/rat. PTU, in the same dose, inhibited thyroid iodide uptake by 78.2 +/- 2.4% (P less than 0.001) and thyroid iodide organification by 36.4 +/- 7.3% (P less than 0.01). Furthermore, the A, B, and C compounds did not inhibit thyroid iodide uptake or iodide organification when administered in higher doses of 5, 5, and 1 mg/rat, respectively. In contrast to these in vivo results, the A, B, and C compounds were more potent than PTU in inhibiting iodide organification in a purified thyroid peroxidase system and in porcine thyroid slices. The concentrations causing 50% inhibition of iodide organification in the purified thyroid peroxidase system were 30, 7, 8, and 14 microM for PTU and the A, B, and C compounds, respectively. However, PTU was far more potent in inhibiting iodide organification in intact incubated thyroid lobes compared to the A, B, and C compounds.(ABSTRACT TRUNCATED AT 400 WORDS)

Animals↗
PubMed1984

New radiotherapeutic techniques in nuclear ophthalmology.

Various aspects of radiotherapeutic techniques used in treating ocular tumors are discussed. Previous and current "standard" modalities are briefly reviewed, including beta and gamma emitters, 60Co, 125I, and charged particles. In particular, emphasis is placed upon techniques under development that use biomolecules to physiologically target radioactive or stable isotopes to ocular melanoma. These procedures include 35S-thiouracil, 127I-deoxyuridine in conjunction with irradiation with photons from 145Sm, neutron capture therapy, and various combinations of the above. Thiouracil shows particular promise because of its incorporation during malanin synthesis in growing melanoma. Radiosensitization and stimulation of Auger cascades via introduction of iodine in DNA followed by irradiation with activating photons of appropriate energy (from 145Sm) has been shown to be effective in vitro. Various molecules may be used to transport boron to ocular melanoma, including thiouracil, thus allowing selective irradiation of tumor cells via 10B (n, alpha) 7Li reaction.

Antibodies, Monoclonal↗
PubMed1977

Role of divalent ions in folding of tRNA.

The native structure of tRNA is not achieved in low salt (4.5 mM Na+, 25 degrees C), but can be restored by addition of divalent ions. We have explored the structure of the central region in Escherichia coli tRNAfMet by absorption and emission spectroscopy of 4-thiouracil, and the structure of the anticodon loop in yeast tRNAPhe by fluorescence of the 'Y' base, versus the number of manganese ions bound to tRNA, which was derived from electron spin resonance. The fluorescence of the reduced 8-13 photoproduct (in which 4-thiouracil at position 8 is crosslinked to cytosine at position 13) was also analysed. In low salt (e.g. 4.5 mM Na+), the region of 4-thiouracil is affected strongly as the first eight Mn2+ bind to tRNA, whereas the fluorescence of the 'Y' base is affected only after four Mn2+ are bound. Considering the structural similarities of the two tRNAs, this suggests that the reorganisation brought about by divalent ions starts in the central region, the anticodon loop being affected later. The binding of divalent ions to each region starts together with its restructuration. Monovalent ions can substitute for divalent ions in this process, a 15 mM sodium concentration being equivalent to the binding of the first five Mn2+. If divalent ions are then added, even the first ones distribute themselves between both the central and the anticodon region. Alternatively, the renaturation may be achieved by monovalent ions only, implying that no sites exist whose occupancy by divalent ions is crucial for the native structure. These observations suggest that the role and means of divalent ion binding to tRNA are largely explainable in terms of a simple maganese-phosphate binding supplemented by electrostatic interaction with distant phosphates.

Anticodon↗
PubMed1978

A radioimmunoassay for 3,5,3'-triiodothyronine in chicken serum.

A double-antibody radioimmunoassay is described for 3,5,3'-triiodothyronine (T3) in chicken serum. Primary antibody produced in a rabbit had negligible crossreactivity with 3,3,5'-triiodothyronine and thyroxine. The primary antibody diluted 1:1000 bound 50% of a tracer dose of 125I-T3, and a standard curve of 0 to 800 pg/tube was used. Percent binding ranged from 14.1 to 54.1 for a standard curve. Serum volume ranging from 50 to 150 microliter tube did not affect assay results. Coefficient of variation was 2.8% within the assay and 5.5% between assays. The inhibitor 8-anilino-1-naphthalene sulfonic acid was necessary for recovery of T3 from spiked samples. Young chickens had reduced serum T3 concentrations when fed diets containing .1% thiouracil for 14 days when compared with serum T3 concentrations of chickens fed the diet without thiouracil. Feeding .2% thiouracil for 3 days did not affect serum T3 concentration.

Animals↗
PubMed1985

Thyroid and adrenal response to heat stress in chickens and quail differing in heat tolerance.

Three experiments were conducted to evaluate the thyroid and adrenal response in groups of birds with altered heat tolerance. Groups of chickens that had been handled on each of 4 days and a nonhandled control group were bled on the 5th day with or without heating for 1 hr at 50 C. Handling did not affect the thyroid response as indicated by thyroxine (T4) or triiodothyronine (T3) levels. Corticosterone levels were lower in handled birds than nonhandled birds after heating. In a second experiment, groups of broilers were fed a diet containing .2% thiouracil or a control diet. After 2 weeks they were bled either with or without 1 hr of heating at 50 C. The T3 and T4 levels were reduced by thiouracil feeding both with and without heating, but adrenal function was not affected. In Experiment 3, T3 and T4 levels were compared for four lines of Japanese quail. The nongrowth-selected line had higher T3 and T4 levels than growth-selected lines but did not have elevated levels of T3 or T4 in response to heat stress. The growth-selected lines (T, S, and P) responded to heating with increased T3 and T4 levels. Levels of T4 in Line T (selected on a thiouracil diet) after heating were significantly higher than all other lines.

Adrenal Cortex↗
PubMed1991

Influence of diet-mediated maternal thyroid alterations on hatchability and metabolism of turkey embryos.

Large White turkey breeder hens from a strain exhibiting poor hatchability were fed thyroid-altering diets. The following dietary treatments were fed to randomized groups of hens for 15 wk of egg laying: 1) 16.5% protein turkey breeder diet (control), 2) the control diet containing 2.1 ppm supplemental iodine, 3) the control diet containing .1% thiouracil, and 4) the control diet containing .5 ppm triiodothyronine (T3). Blood samples were taken from hatching embryos from hens fed each diet. Embryonic hearts and livers were weighted prior to and during pipping as well as after hatching. Blood plasma was analyzed for thyroxine (T4), T3, and glucose. Livers were assayed for glucose-6-phosphatase activity. Supplemental maternal dietary iodine elevated embryonic T4 concentrations prior to pipping. Dietary T3 and iodine increased hepatic glucose-6-phosphatase activity and blood plasma glucose concentration prior to pipping. Feeding thiouracil increased embryonic liver weights but decreased heart and body weights. Blood plasma T4 was elevated in embryos from hens fed thiouracil but blood glucose levels were depressed because of a lack of increased glucose-6-phosphatase activity. Feeding iodine decreased the enzyme activity at internal pipping. It is suggested from the data that maternal thyroid metabolism may influence hatchability via embryonic thyroid and carbohydrate metabolism during hatching.

Animals↗
PubMed1975

Thyroid cell proliferation in rats and induction of tumors by X-rays.

There are very few proliferating cells in the thyroid gland of normal adult rats, as measured by the labeling and mitotic index. One-tenth % 4-methyl-2-thiouracil in drinking water induced an exponential increase of thyroid weight after a lag phase of 2 days; the increase continued for 8 days and was followed by a plateau phase. The following sequence of events was found for the number of dividing follicular and stroma cells as well as for DNA synthesis: no significant changes during the 1st 2 days, a sharp increase between the 2nd and 8th days, a decrease between the 8th and 14th days, and an almost constant flow until the 24th day. Three-hundred rads of X-rays given to a nonproliferating thyroid gland induced tumor growth in 25% of the animals 18 months after irradiation. The same dose of irradiation, applied to a proliferating thyroid gland, increased the tumor incidence to 30% when administered in the lag phase, to 75% when administered at the peak of the proliferating phase, and to 62.5% when administered at the plateau phase. Subsequent treatment of irradiated animals with 4-methyl-2-thiouracil enhanced the number and the size of the thyroid tumors and lead to the occurrence of more carcinomas than appeared in animals treated with X-rays only or 4-methyl-2-thiouracil only.

Animals↗
PubMed1984

Optically detected magnetic resonance of Escherichia coli glutamic acid specific transfer ribonucleic acid and its anticodon-anticodon complex with yeast phenylalanine-specific transfer ribonucleic acid.

The low-temperature phosphorescence and the optically detected magnetic resonance (ODMR) spectra of Escherichia coli tRNA2Glu and its anticodon-anticodon complex with yeast tRNAPhe are reported. The ODMR signals are assigned to the modified base 5-[(methylamino)-methyl]-2-thiouracil (mnm5S2U) located at the "wobble" position of the anticodon. The zero-field splittings (zfs) are larger than those found for 1-methyl-2-thiouracil previously studied in a 1-methyluracil host system by ODMR. They are comparable, however, to those found for neat, polycrystalline 1-methyl-2-thiouracil and for the latter dissolved in ethyl acetate solvent. In the polycrystalline sample, five traps with widely varying zfs are assigned. A very large (15-25%) reduction in the D parameter of mnm5S2U is found to occur on formation of the anticodon-anticodon complex with yeast tRNAPhe. Additional ODMR signals found in the complex are assigned to the wybutine base of yeast tRNAPhe. The extreme sensitivity of the zfs parameters of S2U to environmental perturbations is ascribed to the variable involvement of the heavy atom containing chromophore, C = S, in the triplet-state wave function, which is largely localized on the C = C - C = O portion of the molecule.

Anticodon↗
PubMed1993

2-Thio derivatives of dUrd and 5-fluoro-dUrd and their 5'-monophosphates: synthesis, interaction with tumor thymidylate synthase, and in vitro antitumor activity.

A convenient synthesis of 5-fluoro-2-thiouracil (11) is based on hydrolytic deamination of 5-fluoro-2-thiocytosine (9). Lewis acid-catalyzed condensation of di-TMS-5-fluoro-2-thiouracil (13) or di-TMS-2-thiouracil (14) with 2-deoxy-3,5-di-O-p-toluyl-D-ribofuranosyl chloride (15) led to mixtures of the beta- and alpha-anomers of 3',5'-toluylated 2'-deoxy-5-fluoro-2-thiouridine (16 and 18) or 2'-deoxy-2-thiouridine (17 and 19), each of which was deblocked with MeOH-NH3 to give the desired free anomeric nucleoside pairs 1, 5 and 3, 7, respectively. These were selectively converted to the corresponding 5'-monophosphates 2, 6 and 4, 8, with the aid of the wheat shoot phosphotransferase system. Conformations of the nucleosides 1, 3, 5, 7 are deduced from 1H NMR spectra, and circular dichroism spectra for nucleotide anomeric pairs 2, 6 and 4, 8 are reported. Whereas beta-2-thio-dUMP (4) was a good substrate (Km approximately 10(-5) M), beta-5-fluoro-2-thio-dUMP (2) proved to be a potent competitive, slow-binding inhibitor (Ki approximately 10(-8) M) of the purified enzymes from Ehrlich ascites carcinoma and L1210 cells. The alpha-anomer 6 was a weak inhibitor, with Ki in the mM range, and its congener 8 hardly interacted with the enzyme. The beta-anomer 1 exhibited antitumor activity in a mouse leukemic cell line L5178Y (IC50 approximately 10(-6) M), hence 40-100-fold weaker than 5-fluoro-dUrd. Its alpha-anomer 5 was 10-fold less active, but exhibited at least 10-fold higher selectivity with respect to the tumor cells than the beta-anomer 1.

3T3 Cells↗
PubMed1992

Synthesis and antiviral activity of deoxy analogs of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT) as potent and selective anti-HIV-1 agents.

The effect of substitution in the acyclic structure of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)-thymine (HEPT) on anti-HIV-1 activity was investigated by synthesizing a series of deoxy analogs and related compounds. Preparation of 1-[(2-alkyloxyethoxy)methyl]-6- (phenylthio)thymine (2-4) derivatives was carried out based on alkylation of HEPT with primary alkyl halides. Preparation of the 1-[(alkyloxy)methyl]-6-(phenylthio)thymine (26-31) and 1-[(alkyloxy)methyl]-6-(arylthio)-2-thiouracil (32-45) derivatives was carried out on the basis of LDA lithiation of 1-[(alkyloxy)-methyl]thymine (9-14) and 1-[(alkyloxy)methyl]-2-thiouracil (15-25) followed by reaction with diaryl disulfides. The oxidative hydrolysis of the 2-thiouracil derivatives gave 1-[(alkyloxy)methyl]-6-(arylthio)uracil derivatives (46-57). 1-Alkyl-6-(phenylthio)thymine (59-61) derivatives were prepared on the basis of alkylation of 6-(phenylthio)thymine (58). Methylation of the hydroxyl group of HEPT did not affect the anti-HIV-1 activity of HEPT. Substitution of the 1-(2-hydroxyethoxy)methyl group by ethyl, butyl, methoxymethyl, (propyloxy)methyl, and (butyloxy)-methyl groups somewhat improved the original anti-HIV-1 activity of HEPT. Substitution with ethoxymethyl and (benzyloxy)methyl groups further potentiated the activity [EC50: 1-(ethoxy-methyl)-6-(phenylthio)thymine (27), 0.33 microM; 1-[(benzyloxy)methyl]-6-(phenylthio)thymine (31), 0.088 microM]. When the 5-methyl group of 27 and 31 was replaced by an ethyl or an isopropyl group, the anti-HIV-1 activity was improved remarkably [EC50: 5-ethyl-1-(ethoxymethyl)-6-(phenylthio)-uracil (46), 0.019 microM; 5-ethyl-1-[(benzyloxy)methyl]-6-(phenylthio)uracil (52), 0.0059 microM; 5-isopropyl-1-(ethoxymethyl)-6-(phenylthio)uracil (55), 0.012 microM; 5-isopropyl-1-[(benzyloxy)methyl]-6-(phenylthio)uracil (56), 0.0027 microM]. Introduction of two m-methyl groups into the phenylthio ring also potentiated the activity.

Antiviral Agents↗